China
· Delayed Price · Currency is CNY Shenzhen Salubris Pharmaceuticals Company Description
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices in China.
The company is involved in the production and supply of pharmaceutical products in the fields of chronic diseases, including cardiovascular and cerebrovascular diseases, diabetes, oncology, osteoporosis, anti-infective diseases, and chronic kidney diseases.
It also engages in the research and development, production, and sale of high-end interventional medical devices, such as cardiovascular and cerebrovascular, peripheral vascular, structural heart disease, electrophysiology, and cardiac rhythm management.
The company was incorporated in 1998 and is headquartered in Shenzhen, China. Shenzhen Salubris Pharmaceuticals Co., Ltd. operates as a subsidiary of Salubris Pharmaceuticals Co., Ltd.
| Country | China |
| Founded | 1998 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,596 |
| CEO | Jie Yan |
Contact Details
Address: No. 289 Digital Peninsula Shenzhen, 518017 China | |
| Website | salubris.com |
Stock Details
| Ticker Symbol | 002294 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000FW8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jie Yan | GM and Director |
| Yun Kong CPA | Chief Financial Officer, Accounting Supervisor and Financial Manager |
| Ping Chen | Deputy General Manager |
| Jianfeng Yang | Secretary of the Board of Directors and Non Independent Director |
| Song Ping Zhao | Deputy General Manager |
| Dr. Xie Heng M.D., Ph.D. | Chief Medical Officer |